Brind.
  1. UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector.

UnitedHealth Group reported poor earnings on July 30, 2025.

2 reports, 1 independent Updated Jul 30
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

UnitedHealth Group reported poor earnings on July 30, 2025.

Who's involved

What this event is mainly about
UnitedHealth GroupMyriad Genetics

How it developed

Newest first. Tap a step to see who reported it.
  1. UHG's poor earnings cast a pall over the healthcare sector.1 source
  2. UHG's poor results are linked to sector-wide negative sentiment and integrated medical device supply chains.1 source

Keep exploring

Part of

UnitedHealth Group, Myriad Genetics, and NeoGenomics are involved in a situation concerning the cancer diagnostics space and weaknesses in the broader healthcare sector. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • StockStoryWhy Myriad Genetics (MYGN) Shares Are Falling Today Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 3.8% in the afternoon session after weakness in the healthcare sector became p
  • StockStoryWhy Owens & Minor (OMI) Stock Is Down Today Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3.5% in the afternoon session after the broader healthcare sector traded lower